More success for MS treatment
Brainsway’s non-invasive proprietary coil has successfully demonstrated that it can stimulate the motor cortex for the lower limbs in patients with advanced multiple sclerosis.
Medical clowns are seriously good
The International Conference on Medicine and Medical Clowning is taking place currently in Jerusalem. Clown therapy is becoming one of Israel’s most important exports.
Given Imaging – the inside story
Israel’s Given Imaging makes the world-famous PillCam miniature camera and developed the unique Bravo pH capsule that diagnoses sufferers of Gastroesophageal Reflux Disease. The video celebrates Given Imaging’s 10th anniversary of its NASDAQ listing - an inspiring Israeli success story.
Better heart function, without surgery
Israel’s Enopace Biomedical is developing a non-invasive implant that prevents heart failure by easing the pressure in the left ventricle and improving blood flow to the heart. It could be the biggest breakthrough treatment for congestive heart failure.
Israeli MS drug is the most effective
The results of a five-year study shows that Teva’s Copaxone was the best of all current drug treatments for controlling the disease’s adverse impact on patients’ brain volume.
Surgeon saves child that swallowed screw
Surgeons at Petah Tikva’s Children’s Medical Centre removed a 3.5 cm screw that had been swallowed by a three-year old boy. Dr Noam Zavit used a tiny “basket” to pick up the screw and pull it out through the oesophagus and throat. In August, Dr Zavit pulled an open safety pin from the throat of an 11-month-old baby.
Artificial brain restores motor function in rodent
Tel Aviv University scientist Matti Mintz successfully implanted a robotic cerebellum into the skull of a rodent with brain damage, allowing it to function normally again.
Treatment for Haemophilia sufferers
Israeli biotech Prolor reported positive results in animal trials of its haemophilia drug Factor VIIa-CTP.
Pancreatic cancer drug is fast-tracked
The US Food and Drugs Administration has given priority approval to new treatment BC819 from Israel’s Biocancell Therapeutics.
Canadians will sleep better
Canada has given approval for Israel’s WideMed to market its Morpheus OX and HX sleep apnea monitoring systems.